Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn's Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa Study

William J Sandborn, P Rutgeerts, Jean-Frédéric Colombel, Subrata Ghosh, Robert Petryka, Bruce E. Sands, Pranab Mitra, Allison Luo

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)
188 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn's Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa Study'. Together they form a unique fingerprint.

Medicine & Life Sciences